Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Change-In-Cash" stands at -76.53 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Kyowa Kirin Co Ltd's second quarter result of 20.23 Billion JPY for the item "Change In Cash" represents an increase of 166.75 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 20.23 Billion JPY for the item "Change In Cash" represents an increase of 192.03 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of -76.53 Billion JPY for the item "Change In Cash" represents an increase of 35.55 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -15.54 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -15.54 Billion Japanese Yens.
The 3 year change is -123.66 Billion Japanese Yens.
The 5 year change is -309.13 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Cash | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Cash | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Cash | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Cash | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change In Cash | 280,205,508,085.11 |